Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Assessing retinal ganglion cell damage.

Smith CA, Vianna JR, Chauhan BC.

Eye (Lond). 2017 Feb;31(2):209-217. doi: 10.1038/eye.2016.295. Epub 2017 Jan 13. Review.

PMID:
28085141
2.

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

Bennett JL, de Seze J, Lana-Peixoto M, Palace J, Waldman A, Schippling S, Tenembaum S, Banwell B, Greenberg B, Levy M, Fujihara K, Chan KH, Kim HJ, Asgari N, Sato DK, Saiz A, Wuerfel J, Zimmermann H, Green A, Villoslada P, Paul F; GJCF-ICC&BR.

Mult Scler. 2015 May;21(6):678-88. doi: 10.1177/1352458514567216. Epub 2015 Feb 6. Review.

3.

Correlation between SD-OCT, immunocytochemistry and functional findings in an animal model of retinal degeneration.

Cuenca N, Fernández-Sánchez L, Sauvé Y, Segura FJ, Martínez-Navarrete G, Tamarit JM, Fuentes-Broto L, Sanchez-Cano A, Pinilla I.

Front Neuroanat. 2014 Dec 22;8:151. doi: 10.3389/fnana.2014.00151. eCollection 2014.

4.

Characterization of light lesion paradigms and optical coherence tomography as tools to study adult retina regeneration in zebrafish.

Weber A, Hochmann S, Cimalla P, Gärtner M, Kuscha V, Hans S, Geffarth M, Kaslin J, Koch E, Brand M.

PLoS One. 2013 Nov 26;8(11):e80483. doi: 10.1371/journal.pone.0080483. eCollection 2013.

5.

Potential role of retina as a biomarker for progression of Parkinson's disease.

Tian T, Zhu XH, Liu YH.

Int J Ophthalmol. 2011;4(4):433-8. doi: 10.3980/j.issn.2222-3959.2011.04.21. Epub 2011 Aug 18.

6.

Swept source/Fourier domain polarization sensitive optical coherence tomography with a passive polarization delay unit.

Baumann B, Choi W, Potsaid B, Huang D, Duker JS, Fujimoto JG.

Opt Express. 2012 Apr 23;20(9):10229-41. doi: 10.1364/OE.20.010229.

7.

Hyperautofluorescent ring in autoimmune retinopathy.

Lima LH, Greenberg JP, Greenstein VC, Smith RT, Sallum JM, Thirkill C, Yannuzzi LA, Tsang SH.

Retina. 2012 Jul;32(7):1385-94. doi: 10.1097/IAE.0b013e3182398107.

8.

Optical coherence tomography: history, current status, and laboratory work.

Gabriele ML, Wollstein G, Ishikawa H, Kagemann L, Xu J, Folio LS, Schuman JS.

Invest Ophthalmol Vis Sci. 2011 Apr 14;52(5):2425-36. doi: 10.1167/iovs.10-6312. Print 2011 Apr. Review.

9.

Optic nerve crush mice followed longitudinally with spectral domain optical coherence tomography.

Gabriele ML, Ishikawa H, Schuman JS, Ling Y, Bilonick RA, Kim JS, Kagemann L, Wollstein G.

Invest Ophthalmol Vis Sci. 2011 Apr 6;52(5):2250-4. doi: 10.1167/iovs.10-6311.

10.

Translational research in neurology and neuroscience 2010: multiple sclerosis.

Stüve O, Kieseier BC, Hemmer B, Hartung HP, Awad A, Frohman EM, Greenberg BM, Racke MK, Zamvil SS, Phillips JT, Gold R, Chan A, Zettl U, Milo R, Marder E, Khan O, Eagar TN.

Arch Neurol. 2010 Nov;67(11):1307-15. doi: 10.1001/archneurol.2010.158. Epub 2010 Jul 12. Review.

11.

Reproducibility of spectral-domain optical coherence tomography total retinal thickness measurements in mice.

Gabriele ML, Ishikawa H, Schuman JS, Bilonick RA, Kim J, Kagemann L, Wollstein G.

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6519-23. doi: 10.1167/iovs.10-5662. Epub 2010 Jun 23.

12.

Fundus autofluorescence and optical coherence tomography of congenital grouped albinotic spots.

Kim DY, Hwang JC, Moore AT, Bird AC, Tsang SH.

Retina. 2010 Sep;30(8):1217-22. doi: 10.1097/IAE.0b013e3181cea5a5.

13.

Spectral domain optical coherence tomography in mouse models of retinal degeneration.

Huber G, Beck SC, Grimm C, Sahaboglu-Tekgoz A, Paquet-Durand F, Wenzel A, Humphries P, Redmond TM, Seeliger MW, Fischer MD.

Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5888-95. doi: 10.1167/iovs.09-3724. Epub 2009 Aug 6.

14.

Structural assessment of hyperautofluorescent ring in patients with retinitis pigmentosa.

Lima LH, Cella W, Greenstein VC, Wang NK, Busuioc M, Smith RT, Yannuzzi LA, Tsang SH.

Retina. 2009 Jul-Aug;29(7):1025-31. doi: 10.1097/IAE.0b013e3181ac2418.

15.

Retinal tumor imaging and volume quantification in mouse model using spectral-domain optical coherence tomography.

Ruggeri M, Tsechpenakis G, Jiao S, Jockovich ME, Cebulla C, Hernandez E, Murray TG, Puliafito CA.

Opt Express. 2009 Mar 2;17(5):4074-83.

16.

Developing SDOCT to assess donor human eyes prior to tissue sectioning for research.

Brown NH, Koreishi AF, McCall M, Izatt JA, Rickman CB, Toth CA.

Graefes Arch Clin Exp Ophthalmol. 2009 Aug;247(8):1069-80. doi: 10.1007/s00417-009-1044-3. Epub 2009 Feb 19.

17.

In vivo imaging of the mouse model of X-linked juvenile retinoschisis with fourier domain optical coherence tomography.

Xu J, Molday LL, Molday RS, Sarunic MV.

Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2989-93. doi: 10.1167/iovs.08-2542. Epub 2009 Jan 31.

18.

Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema.

Doukas J, Mahesh S, Umeda N, Kachi S, Akiyama H, Yokoi K, Cao J, Chen Z, Dellamary L, Tam B, Racanelli-Layton A, Hood J, Martin M, Noronha G, Soll R, Campochiaro PA.

J Cell Physiol. 2008 Jul;216(1):29-37. doi: 10.1002/jcp.21426.

19.

A reference standard for the measurement of macular oedema.

Goatman KA.

Br J Ophthalmol. 2006 Sep;90(9):1197-202. Review.

Supplemental Content

Support Center